119 related articles for article (PubMed ID: 26847876)
1. Oncology Pathways-Preventing a Good Idea From Going Bad.
Polite BN; Page RD; Nabhan C
JAMA Oncol; 2016 Mar; 2(3):297-8. PubMed ID: 26847876
[No Abstract] [Full Text] [Related]
2. Is Medicare ready for oncology clinical pathways?
Mehr SR
Am J Manag Care; 2014 Feb; 20(2 Spec No.):E1. PubMed ID: 25618386
[No Abstract] [Full Text] [Related]
3. Healthcare reimbursement for oncology care.
Bence S
Pa Nurse; 2006 Jun; 61(2):17, 29. PubMed ID: 16871983
[No Abstract] [Full Text] [Related]
4. Reforming the payment system for medical oncology.
Bach PB
JAMA; 2013 Jul; 310(3):261-2. PubMed ID: 23817729
[No Abstract] [Full Text] [Related]
5. US Oncology going private.
Piotrowski J
Mod Healthc; 2004 Mar; 34(13):8-9, 13. PubMed ID: 15077351
[No Abstract] [Full Text] [Related]
6. Current issues in oncology reimbursement.
Bailes JS
Oncology (Williston Park); 1995 Nov; 9(11 Suppl):185-9. PubMed ID: 8608051
[TBL] [Abstract][Full Text] [Related]
7. Is physician employment by health systems an answer?
Gosfield AG
J Oncol Pract; 2014 Jan; 10(1):55-7. PubMed ID: 24151328
[No Abstract] [Full Text] [Related]
8. HCFA's new shift. Implications for radiation therapy.
Vann AM
Adm Radiol; 1989 Apr; 8(4):40-1. PubMed ID: 10303516
[No Abstract] [Full Text] [Related]
9. Medicare and drug pricing.
Iglehart JK
N Engl J Med; 2003 Apr; 348(16):1590-7. PubMed ID: 12700381
[No Abstract] [Full Text] [Related]
10. Navigating the business of oncology for 2008.
Crisafulli T
Semin Oncol; 2008 Feb; 35(1):1-5. PubMed ID: 18308138
[No Abstract] [Full Text] [Related]
11. MACRA in Oncology Care: Are We Ready?
Nabhan C; Tchafa A; Feinberg BA
J Oncol Pract; 2017 Dec; 13(12):777-779. PubMed ID: 29144865
[No Abstract] [Full Text] [Related]
12. Should oncologists support the Affordable Care Act?
Kantarjian H; Steensma D; Light D
Lancet Oncol; 2013 Dec; 14(13):1258-9. PubMed ID: 24275127
[No Abstract] [Full Text] [Related]
13. The shortage of essential chemotherapy drugs in the United States.
Gatesman ML; Smith TJ
N Engl J Med; 2011 Nov; 365(18):1653-5. PubMed ID: 22040130
[No Abstract] [Full Text] [Related]
14. Balancing the policy with appropriate patient care.
Stefanacci RG
Manag Care; 2008 Jul; 17(7 Suppl 6):16-9. PubMed ID: 19093335
[TBL] [Abstract][Full Text] [Related]
15. When reimbursement issues go beyond reimbursement.
Abraham BC
J Oncol Manag; 2002; 11(6):31-2. PubMed ID: 12502291
[No Abstract] [Full Text] [Related]
16. Oncology reimbursement overview: drug purchasing arrangements and profitability.
Crisafulli T
Semin Oncol; 2008 Aug; 35(4):321-3. PubMed ID: 18692681
[No Abstract] [Full Text] [Related]
17. Unlisted codes.
Parman CC
J Oncol Manag; 2003; 12(2):6-7. PubMed ID: 12699110
[No Abstract] [Full Text] [Related]
18. The new Medicare bill: far-reaching effects on cancer treatment.
Bailes JS; Coleman T
Clin Adv Hematol Oncol; 2004 May; 2(5):292-4. PubMed ID: 16163195
[TBL] [Abstract][Full Text] [Related]
19. The Oncology Care Model-Why It Works and Why It Could Work Better: Accounting for Novel Therapies in Value-Based Payment.
Lyss AJ; Supalla SN; Schleicher SM
JAMA Oncol; 2020 Aug; 6(8):1161-1162. PubMed ID: 31670756
[No Abstract] [Full Text] [Related]
20. CMS Takes the Lead In Oncology Payment Reform.
Reinke T
Manag Care; 2015 Oct; 24(10):22-5. PubMed ID: 26668887
[No Abstract] [Full Text] [Related]
[Next] [New Search]
